D. Cox

1.8k total citations
65 papers, 1.0k citations indexed

About

D. Cox is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology. According to data from OpenAlex, D. Cox has authored 65 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 19 papers in Epidemiology and 14 papers in Physiology. Recurrent topics in D. Cox's work include Cystic Fibrosis Research Advances (19 papers), Neonatal Respiratory Health Research (14 papers) and Respiratory viral infections research (13 papers). D. Cox is often cited by papers focused on Cystic Fibrosis Research Advances (19 papers), Neonatal Respiratory Health Research (14 papers) and Respiratory viral infections research (13 papers). D. Cox collaborates with scholars based in Ireland, Australia and United Kingdom. D. Cox's co-authors include Peter N. Le Souëf, Jack Goldblatt, Guicheng Zhang, Ingrid A. Laing, James E. Gern, S.‐K. Khoo, Gary C. Geelhoed, Andrew C. Martin, Tressa Pappas and Fue Vang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

D. Cox

60 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Cox Ireland 17 457 402 360 144 135 65 1.0k
Sif Hansdóttir United States 10 333 0.7× 246 0.6× 276 0.8× 158 1.1× 40 0.3× 17 1.3k
Tomoaki Iwanaga Japan 18 485 1.1× 179 0.4× 363 1.0× 112 0.8× 27 0.2× 79 910
Philip Diaz United States 12 707 1.5× 178 0.4× 204 0.6× 45 0.3× 63 0.5× 23 1.2k
Desmond M. Murphy Ireland 19 846 1.9× 154 0.4× 482 1.3× 146 1.0× 75 0.6× 64 1.4k
Sui‐Ling Liao Taiwan 19 324 0.7× 210 0.5× 323 0.9× 72 0.5× 56 0.4× 74 1.0k
Katerina Dimakou Greece 18 1.3k 2.9× 306 0.8× 328 0.9× 39 0.3× 149 1.1× 77 1.5k
Paul K. Keith Canada 23 419 0.9× 151 0.4× 1.0k 2.9× 188 1.3× 90 0.7× 70 2.1k
Heidi Makrinioti United Kingdom 15 280 0.6× 185 0.5× 369 1.0× 295 2.0× 83 0.6× 40 946
Olivier Le Rouzic France 17 601 1.3× 93 0.2× 229 0.6× 75 0.5× 90 0.7× 62 841
Haruhiko Ogawa Japan 18 531 1.2× 146 0.4× 454 1.3× 53 0.4× 83 0.6× 81 1.1k

Countries citing papers authored by D. Cox

Since Specialization
Citations

This map shows the geographic impact of D. Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Cox more than expected).

Fields of papers citing papers by D. Cox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Cox. The network helps show where D. Cox may publish in the future.

Co-authorship network of co-authors of D. Cox

This figure shows the co-authorship network connecting the top 25 collaborators of D. Cox. A scholar is included among the top collaborators of D. Cox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Cox. D. Cox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Urquhart, Don S., Barry Linnane, Clare Saunders, et al.. (2025). ENHANCE: a community partnership charting the evolution of early-life cystic fibrosis disease manifestations in a new era of management. ERJ Open Research. 12(2). 373–2025.
2.
Elnazir, B., Michael Williamson, D. Cox, et al.. (2024). WS15.05 Improvements in structural lung disease in people with CF aged 12 and above on elexacaftor/tezacaftor/ivacaftor are sustained for up to two years. Journal of Cystic Fibrosis. 23. S29–S29. 1 indexed citations
3.
Sinclair, Rosalie, Minmin Wang, Jesse Aaron, et al.. (2024). Four-dimensional quantitative analysis of cell plate development in Arabidopsis using lattice light sheet microscopy identifies robust transition points between growth phases. Journal of Experimental Botany. 75(10). 2829–2847. 4 indexed citations
4.
Cox, D.. (2023). Sepsis – it is all about the platelets. Frontiers in Immunology. 14. 1210219–1210219. 42 indexed citations
5.
6.
Frazer, Kate, D. Cox, Paul Kavanagh, & Cecily Kelleher. (2023). Getting to Tobacco 21: an all-policy consensus is needed to reduce unintended consequences. Health Promotion International. 38(6).
7.
Cox, D., et al.. (2023). Knowledge, attitudes and practices of Irish doctors regarding stop smoking care and electronic cigarettes. Irish Journal of Medical Science (1971 -). 193(2). 783–790. 1 indexed citations
8.
McNally, Paul, B. Elnazir, D. Cox, et al.. (2023). Improvement in Lung Clearance Index and Chest Computed Tomography Scores with Elexacaftor/Tezacaftor/Ivacaftor Treatment in People with Cystic Fibrosis Aged 12 Years and Older – The RECOVER Trial. American Journal of Respiratory and Critical Care Medicine. 208(9). 917–929. 37 indexed citations
9.
McNally, Paul, Barry Linnane, B. Elnazir, et al.. (2023). The clinical impact of Lumacaftor-Ivacaftor on structural lung disease and lung function in children aged 6–11 with cystic fibrosis in a real-world setting. Respiratory Research. 24(1). 199–199. 6 indexed citations
10.
Cox, D., et al.. (2020). A case of COVID-19 in a patient with a univentricular heart post total cavopulmonary connection (Fontan) surgery. Cardiology in the Young. 30(9). 1350–1352. 7 indexed citations
11.
Coughlan, Suzie, et al.. (2020). The role of rhinovirus infections in young children with cystic fibrosis. Journal of Clinical Virology. 129. 104478–104478. 3 indexed citations
12.
Owens, Louisa, Ingrid A. Laing, Guicheng Zhang, et al.. (2017). EFFECTS OF IN UTERO SMOKE EXPOSURE ON LUNG FUNCTION FROM INFANCY TO ADULTHOOD AND THE CONTRIBUTION OF GLUTATHIONE S-TRANSFERASE POLYMORPHISMS. Respirology. 22. 46–46. 2 indexed citations
13.
Cox, D., Joelene Bizzintino, Giovanni Ferrari, et al.. (2013). Human Rhinovirus Species C Infection in Young Children with Acute Wheeze Is Associated with Increased Acute Respiratory Hospital Admissions. American Journal of Respiratory and Critical Care Medicine. 188(11). 1358–1364. 122 indexed citations
14.
Mullane, D., Steve Turner, D. Cox, et al.. (2013). Reduced Infant Lung Function, Active Smoking, and Wheeze in 18-Year-Old Individuals. JAMA Pediatrics. 167(4). 368–368. 20 indexed citations
15.
Cox, D., D. Mullane, Steven W. Turner, et al.. (2011). Associations between bronchiolitis and respiratory outcomes at 18 years in the PIAF birth cohort. European Respiratory Journal. 38(Suppl 55). p1170–p1170. 1 indexed citations
16.
Turner, Steve, et al.. (2011). Early life antecedents of persistent wheeze in young adults. European Respiratory Journal. 38(Suppl 55). p1505–p1505. 1 indexed citations
17.
Bizzintino, J., Ingrid A. Laing, Fue Vang, et al.. (2010). Association between human rhinovirus C and severity of acute asthma in children. European Respiratory Journal. 37(5). 1037–1042. 285 indexed citations
18.
Cox, D., et al.. (2008). Juvenile localised scleroderma: a retrospective review of response to systemic treatment. Irish Journal of Medical Science (1971 -). 177(4). 343–346. 33 indexed citations
19.
Delaney, Bryan, et al.. (2002). Genetic toxicity of a standardized mixture of citrus polymethoxylated flavones. Food and Chemical Toxicology. 40(5). 617–624. 31 indexed citations
20.
Cox, D., et al.. (1991). Life activities following simultaneous pancreatic/renal transplantation: a pilot study. Iowa Research Online (The University of Iowa). 1(1). 15–18. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sif Hansdóttir Breakdown of academic impact, for papers by Tomoaki Iwanaga Breakdown of academic impact, for papers by Philip Diaz Breakdown of academic impact, for papers by Desmond M. Murphy Breakdown of academic impact, for papers by Sui‐Ling Liao Breakdown of academic impact, for papers by Katerina Dimakou Breakdown of academic impact, for papers by Paul K. Keith Breakdown of academic impact, for papers by Heidi Makrinioti Breakdown of academic impact, for papers by Olivier Le Rouzic Breakdown of academic impact, for papers by Haruhiko Ogawa
Rankless by CCL
2026